What is the recommended diagnosis and treatment for suspected Lyme disease after a tick bite, including first‑line oral antibiotics for early localized disease in healthy adults, alternatives for children under 8, pregnant or lactating women, the preferred regimen for disseminated neurologic or cardiac involvement, and criteria for prophylactic doxycycline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lyme Disease: Diagnosis and Treatment

Prophylaxis After Tick Bite

For high-risk tick bites, administer a single dose of doxycycline 200 mg (adults) or 4.4 mg/kg up to 200 mg (children ≥8 years) within 72 hours of tick removal. 1

Criteria for Prophylactic Doxycycline (ALL must be met):

  • Identified Ixodes scapularis tick (reliable species identification) 1
  • Tick attached ≥36 hours (based on engorgement or known exposure time) 1
  • Prophylaxis started within 72 hours of tick removal 1
  • Endemic area with ≥20% tick infection rate (parts of New England, mid-Atlantic, Minnesota, Wisconsin) 1
  • No contraindications to doxycycline 1

Key Points on Prophylaxis:

  • Do NOT use prophylaxis for equivocal or low-risk bites—use wait-and-watch approach instead 1
  • Do NOT test asymptomatic patients for Borrelia exposure after tick bite 1
  • Do NOT substitute amoxicillin for doxycycline prophylaxis in contraindicated patients—observation is preferred given low risk of serious complications 1
  • Submit tick for species identification to confirm Ixodes species 1

Diagnosis of Early Localized Disease (Erythema Migrans)

Diagnose erythema migrans clinically without laboratory testing in patients with compatible skin lesions and tick exposure in endemic areas. 1

Diagnostic Approach:

  • Clinical diagnosis alone is sufficient for typical erythema migrans lesions 1
  • Laboratory testing NOT recommended for typical presentations—serology is often negative early in disease 1
  • Consider antibody testing only for atypical lesions (acute-phase serum, followed by convalescent-phase 2-3 weeks later if negative) 1
  • Do NOT delay treatment while awaiting laboratory confirmation 2

Treatment of Early Localized Disease (Erythema Migrans)

Treat adults with doxycycline 100 mg orally twice daily for 10 days as first-line therapy. 1, 2, 3

First-Line Oral Regimens for Adults:

  • Doxycycline 100 mg twice daily for 10 days (preferred—shorter duration, covers HGA co-infection) 1, 2, 3
  • Amoxicillin 500 mg three times daily for 14 days (alternative first-line) 1, 2, 3
  • Cefuroxime axetil 500 mg twice daily for 14 days (alternative first-line) 1, 2, 3

Doxycycline Administration:

  • Take with 8 ounces of fluid to reduce esophageal irritation 2, 4
  • Can be taken with food to reduce GI intolerance 2, 4
  • Advise sun avoidance due to photosensitivity risk 2, 4

Treatment for Children Under 8 Years

For children <8 years, use amoxicillin 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) for 14 days as first-line therapy. 4, 3

Pediatric First-Line Options:

  • Amoxicillin 50 mg/kg/day in 3 divided doses (max 500 mg/dose) for 14 days 4, 3
  • Cefuroxime axetil 30 mg/kg/day in 2 divided doses (max 500 mg/dose) for 14 days 4, 3

Evolving Evidence on Doxycycline in Young Children:

  • Doxycycline is increasingly used in children <8 years for Lyme disease 5, 6
  • Short courses (≤3 weeks) appear safe with minimal tooth staining risk 5, 6
  • Amoxicillin remains preferred for non-neurological disease in young children, but doxycycline is a safe alternative when needed 5

Treatment for Pregnant or Lactating Women

Treat pregnant and lactating women identically to non-pregnant patients, but avoid doxycycline—use amoxicillin or cefuroxime axetil instead. 1, 3

Regimens for Pregnancy/Lactation:

  • Amoxicillin 500 mg three times daily for 14 days 1, 3
  • Cefuroxime axetil 500 mg twice daily for 14 days 1, 3
  • Doxycycline is relatively contraindicated in pregnancy and lactation 1, 2

Treatment of Disseminated Neurologic Disease

For Lyme meningitis or radiculopathy, use parenteral ceftriaxone 2 g IV daily for 14 days (range 10-28 days). 1

Neurologic Manifestations:

  • Meningitis or radiculopathy: Parenteral regimen (ceftriaxone or penicillin G) for 14 days (10-28 days) 1
  • Cranial nerve palsy alone: Oral regimen (doxycycline, amoxicillin, or cefuroxime) for 14 days (14-21 days) 1
  • Oral doxycycline 200-400 mg/day in 2 divided doses for 10-28 days is an acceptable alternative to IV therapy for neurologic disease 2

Critical Pitfall:

  • Screen for subtle neurologic symptoms (distal paresthesias, memory impairment) before initiating oral therapy—these patients may develop neuroborreliosis and require IV ceftriaxone 3

Treatment of Cardiac Involvement

For Lyme carditis, use oral or parenteral regimens for 14 days (14-21 days) depending on severity. 1

Cardiac Disease Approach:

  • Oral regimen acceptable for mild cardiac involvement 1
  • Parenteral regimen recommended for advanced atrioventricular heart block 1
  • Duration: 14 days (range 14-21 days) 1

Second-Line Agents (Use Only When First-Line Contraindicated)

Macrolides (azithromycin, clarithromycin, erythromycin) are less effective than doxycycline and should only be used when first-line agents are not tolerated. 2, 3

Macrolide Regimens:

  • Azithromycin 500 mg daily for 7-10 days (7 days preferred in US) 1, 3
  • Clarithromycin 500 mg twice daily for 14-21 days 3
  • Erythromycin 500 mg four times daily for 14-21 days 3

Critical Pitfalls to Avoid

Ineffective Antibiotics (NEVER USE):

  • First-generation cephalosporins (cephalexin) are completely ineffective against B. burgdorferi 2, 4, 3
  • Fluoroquinolones, carbapenems, vancomycin, metronidazole, trimethoprim-sulfamethoxazole are not recommended 1
  • Benzathine penicillin G is ineffective 1

Treatment Duration Errors:

  • Do NOT extend treatment beyond 21 days for early Lyme disease—no evidence of benefit 2
  • Do NOT use pulsed-dosing or long-term antibiotic therapy 1

Co-infection Considerations

Consider co-infection with Anaplasma phagocytophilum (HGA) or Babesia microti in patients with severe symptoms, high fever >48 hours despite treatment, or unexplained cytopenias. 1, 3

When to Suspect Co-infection:

  • High-grade fever persisting >48 hours despite appropriate Lyme treatment 1, 3
  • Unexplained leukopenia, thrombocytopenia, or anemia 1, 3
  • More severe initial symptoms than typical for Lyme disease alone 1
  • Resolved erythema migrans but worsening viral-like symptoms 1

Co-infection Management:

  • Doxycycline covers HGA (extend to minimum 10 days if anaplasmosis suspected) 2, 3
  • Doxycycline does NOT cover babesiosis—requires atovaquone plus azithromycin 3
  • In endemic areas with higher co-infection rates, maintain heightened suspicion 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lyme Disease Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preferred Treatment for Erythema Migrans

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric Doxycycline Dosing for Lyme Disease Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Doxycycline for the Treatment of Lyme Disease in Young Children.

The Pediatric infectious disease journal, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.